RADIO Meso study publishes results

The RADIO Meso study is now complete and researchers have published the final report. The study used interviews with patients, family members and healthcare professionals with the aim of improving the way in which patients are given a diagnosis of mesothelioma.

The feedback was collated and the researchers have produced a top ten list of recommendations for healthcare professionals to use when delivering diagnoses.

RADIO Meso (Receiving a diagnosis of mesothelioma) is a research project, funded by Mesothelioma UK and being carried out by researchers at the University of Sheffield. The project aims to identify ways to improve the patient and family carer experience of receiving a diagnosis of mesothelioma.

The researchers carried out a focus group at the Mesothelioma UK Patient and Carer Day in October 2017. Patients and family carers were asked to recall their experience of receiving a mesothelioma diagnosis and to tell the team ‘what went well?’ and ‘what could have been better?’. With this in mind, the team then contemplated what the ‘ideal’ way to receive a diagnosis would be.

All responses have been incredibly valuable and, after collating them the researchers were able to identify key themes. To summarise some of these, patients and family carers said they valued: prior warning that it could be bad news, time to ask questions once the news has sunk in and a point of contact during this difficult time.

Alongside this, participants overwhelmingly drew attention to and praised the important role of health care professionals, especially clinical nurse specialists.

Challenges that repeatedly arose across patient and family carer stories included the long and winding road to reach a diagnosis and difficulty accessing good quality, reliable information and local support.

Examples of communication styles and words and phrases that were helpful and unhelpful were also identified.

The researchers are very much looking forward to discussing these in more detail with patients and carers over the coming months and are hoping to produce recommendations for consultation early in 2018.

Access to immunotherapy update

As you may be aware from previous issues of our magazine, first line immunotherapy (nivolumab and ipilimumab) for the treatment of mesothelioma is currently under consideration by the National Institute for Health and Care Excellence (NICE) following the results of...

Mesothelioma UK partners with Healthinote

Mesothelioma UK has joined Healthinote, an online digital platform allowing doctors, nurses and pharmacists to find and share reliable health information with their patients. Used by over 3,000 GP practices in the UK, Heathinote enables people to be given an...

New Chemotherapy Booklet

Our new booklet Chemotherapy for Mesothelioma addresses key questions people with mesothelioma may have if they are offered chemotherapy. “Whether to accept chemotherapy is not always a straightforward decision for people with mesothelioma. Our new booklet can help...

Mesothelioma UK appoints new Head of Nursing

Leah Taylor has been appointed as the new Head of Nursing for Mesothelioma UK. In this role, Leah will work closely with the charity’s operational team and trustees, and will provide strategic leadership of the charity’s UK network of 34 Clinical Nurse Specialists....

PIF TICK certification for our patient information

We know how overwhelming a diagnosis of mesothelioma can be, and how good written information can play a vital part in helping people make informed choices. This is why we’re so pleased to have been recertified under the PIF TICK scheme, demonstrating our commitment...